Tagged with EG

Turkey Selim Giray, the recently appointed VP and general manager of GSK Turkey, provides insights into the company’s eye-catching footprint and commitment to Turkey, his ambition to integrate into the market’s Top Four ranking in the coming years, as well as his aspirations to see the industry and the government work…

Turkey In Summer 2018, we spoke to Adriano Antonio Treve, then general manager of Roche Turkey, now Area Head Central Eastern Europe, Turkey, Russia, Central Asia, Iran, Pakistan & Indian Subcontinent. Treve provided insights into the main opportunities and challenges of the Turkish market, Roche’s unrivalled commitment to making a difference…

Turkey Elif Aral, country manager of Pfizer Turkey, stresses that Turkey will continue to be perceived as essential and important, where healthcare is a top priority with its young but aging population. In addition, as the newly appointed Chairman of the Board of Directors of the Association of Research-Based Pharmaceutical Companies…

Turkey Mark Dekker, general manager of Astellas in Turkey, describes the ever-increasing commitment of the company to Turkey and the recent doubling of Astellas’ portfolio in the country, while pinpointing the next steps ahead to further improve access to innovation in Turkey and ensure the country continues to be seen as…

Hong Kong Merck Hong Kong’s Hee-sun Lee gives her first impressions of the Hong Kong market, her main priorities, upcoming product launches and tapping into the territory’s R&D ecosystem. Hee-sun, having joined Merck Pharmaceutical Hong Kong in February 2018 from the South Korean affiliate, what are your first impressions of the market…

Portugal Francisco del Val, recently nominated general manager of the business unit Sanofi Genzyme and country head of Sanofi Portugal, has two decades’ experience in the pharma industry. In his first interview in Portugal, Francisco shares with us his priorities and his vision, highlighting the importance of diversification, and innovation through…

Cyprus Sotos Jacovides is managing the company M.S. Jacovides & Co. Ltd alongside his three brothers, Aris, Alex and Savvas, to continue on the legacy of their father. Now strongly established as one of the leading healthcare companies in Cyprus, M.S. Jacovides is looking forward to entering new and promising niches…

UK Three years into his role as general manager of Sobi’s UK and Republic of Ireland operations, Neil Dugdale introduces the scope of operations of the Swedish rare disease player to our audience, highlighting the company’s unique positioning in working closely with patient groups to drive forward better understanding of unmet…

Cyprus Michael Neoptolemou, managing director at Remedica, takes us through the evolution of one of the leading pharmaceutical companies in Cyprus and outlines their successful business model. Neoptolemou also highlights the key opportunities the recent acquisition by Ascendis Health in 2016 has brought to Remedica and how it will further enhance…

Turkey Gilles Renacco, the recently appointed general manager of Servier Turkey, provides insights into the successful localization process pioneered by Servier in the country, where 98 percent of the company’s products are nowadays locally manufactured. He also highlights the strategic importance of the country for the Servier Group, his key priorities…

Cyprus With more than 25 years of experience, Kyriakos Mikellis is actively involved in the Cypriot healthcare environment as the President of the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) as well as the Country Lead Cyprus and Malta for Pfizer. He shares in this exclusive interview the important…

UK Richard Erwin, general manager of Roche Products Ltd in the UK, speaks out about the challenges facing the company, from market access to uptake of innovation, to collaborating with diverse stakeholder groups, improving outcomes for UK patients.   We do see a will and an intent from stakeholders, from government…